Form 4: Herbalife CFO John DeSimone Awarded Stock Appreciation Rights
SEC Form 4 Filing
Herbalife CFO John DeSimone received stock appreciation rights (SARs) under the company's 2023 Stock Incentive Plan.
Summary
- John DeSimone, the Chief Financial Officer of Herbalife Ltd., was granted stock appreciation rights (SARs) on March 25, 2024.
- The SARs, totaling 1,532,769, were awarded under the Herbalife Ltd. 2023 Stock Incentive Plan.
- These SARs will vest in two installments: 50% on March 25, 2025, and the remaining 50% on March 25, 2026, contingent upon DeSimone's continued service as CFO.
- The exercise price of the SARs is $9.33.
- The SARs expire on March 25, 2034.
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, indicating stability and alignment of interests. It's a neutral-positive event.
Positives
- The granting of SARs aligns the CFO's interests with those of the shareholders, incentivizing him to improve the company's performance.
- The vesting schedule encourages long-term commitment from the CFO.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedule of the SARs.
Industry Context
Granting stock appreciation rights is a common practice in corporate compensation to incentivize executives and align their interests with shareholders. The specific terms of the grant, such as the vesting schedule and exercise price, are tailored to the company's specific circumstances and compensation philosophy.
Comparison to Industry Standards
- Stock appreciation rights are a common form of equity compensation, often used alongside or in place of stock options.
- Companies like Coca-Cola and PepsiCo also utilize equity-based compensation for their executives, with vesting schedules and performance metrics tailored to their specific business goals.
- The vesting schedule of Herbalife's SARs is fairly standard, with vesting occurring over a period of two years.
Stakeholder Impact
- Shareholders: The grant of SARs aligns the CFO's interests with those of the shareholders, potentially leading to improved company performance.
- Employees: The grant may have a positive impact on employee morale, as it demonstrates the company's commitment to rewarding its executives.
Key Dates
| Date | Description |
|---|---|
| 03/25/2024 | Date of transaction: Grant of stock appreciation rights. |
| 03/25/2025 | First vesting date: 50% of SARs vest. |
| 03/25/2026 | Second vesting date: Remaining 50% of SARs vest. |
| 03/25/2034 | Expiration date of the SARs. |
| 03/27/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.